4/27
07:00 am
ew
Edwards Lifesciences (EW) had its "overweight" rating reaffirmed by Barclays PLC.
Low
Report
Edwards Lifesciences (EW) had its "overweight" rating reaffirmed by Barclays PLC.
4/24
12:00 pm
ew
Edwards Lifesciences (EW) was given a new $90.00 price target by Truist Financial Corporation.
Low
Report
Edwards Lifesciences (EW) was given a new $90.00 price target by Truist Financial Corporation.
4/24
10:42 am
ew
Edwards Lifesciences raises FY26 guidance following strong Q1 [Yahoo! Finance]
Low
Report
Edwards Lifesciences raises FY26 guidance following strong Q1 [Yahoo! Finance]
4/24
10:00 am
ew
Edwards Lifesciences (EW) was given a new $85.00 price target by Canaccord Genuity Group Inc..
Low
Report
Edwards Lifesciences (EW) was given a new $85.00 price target by Canaccord Genuity Group Inc..
4/24
10:00 am
ew
Edwards Lifesciences (EW) had its "outperform" rating reaffirmed by Evercore Inc.
Low
Report
Edwards Lifesciences (EW) had its "outperform" rating reaffirmed by Evercore Inc.
4/24
08:20 am
ew
Edwards Lifesciences (EW) had its price target raised by Robert W. Baird from $85.00 to $87.00. They now have a "neutral" rating on the stock.
Low
Report
Edwards Lifesciences (EW) had its price target raised by Robert W. Baird from $85.00 to $87.00. They now have a "neutral" rating on the stock.
4/24
08:20 am
ew
Edwards Lifesciences (EW) had its price target raised by BTIG Research from $98.00 to $100.00. They now have a "buy" rating on the stock.
Low
Report
Edwards Lifesciences (EW) had its price target raised by BTIG Research from $98.00 to $100.00. They now have a "buy" rating on the stock.
4/23
09:42 pm
ew
Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript [Seeking Alpha]
Low
Report
Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript [Seeking Alpha]
4/23
04:15 pm
ew
Edwards Lifesciences Reports First Quarter Results
Medium
Report
Edwards Lifesciences Reports First Quarter Results
4/22
06:05 am
ew
Edwards Lifesciences (EW) had its "hold (c)" rating reaffirmed by
Weiss Ratings.
Low
Report
Edwards Lifesciences (EW) had its "hold (c)" rating reaffirmed by
Weiss Ratings.
4/16
07:05 am
ew
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
Low
Report
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
4/15
06:51 am
ew
Artisan Mid Cap Fund Q1 2026 Portfolio Activity [Seeking Alpha]
Low
Report
Artisan Mid Cap Fund Q1 2026 Portfolio Activity [Seeking Alpha]
4/13
12:08 pm
ew
Edwards Lifesciences (EW) was given a new $95.00 price target by Mizuho.
Low
Report
Edwards Lifesciences (EW) was given a new $95.00 price target by Mizuho.
4/4
03:18 pm
ew
Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026
Low
Report
Marie O'Malley to Speak on Manufacturing Tradeoffs Panel at MPP West 2026
4/2
02:25 am
ew
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]
Low
Report
A new valve, a new playbook: How Anteris is trying to reshape a $10B heart market [Yahoo! Finance]
4/1
08:14 am
ew
Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.
Low
Report
Edwards Lifesciences (EW) was upgraded by Wolfe Research from "peer perform" to "outperform". They now have a $92.00 price target on the stock.
4/1
04:47 am
ew
Boston Scientific: From Hypergrowth To Durable Compounding [Seeking Alpha]
Low
Report
Boston Scientific: From Hypergrowth To Durable Compounding [Seeking Alpha]
3/31
07:20 am
ew
Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution [Yahoo! Finance]
Low
Report
Philips Wins FDA 510(k) Clearance for AI Heart Valve Repair Solution [Yahoo! Finance]
3/30
10:27 am
ew
Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance]
Low
Report
Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits [Yahoo! Finance]
3/30
10:00 am
ew
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
Low
Report
Two Year Data on Edwards Lifesciences’ EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
3/27
11:56 am
ew
Philips wins FDA clearance for imaging device developed with Edwards [Yahoo! Finance]
Low
Report
Philips wins FDA clearance for imaging device developed with Edwards [Yahoo! Finance]
3/21
05:31 pm
ew
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now? [Yahoo! Finance]
Low
Report
Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now? [Yahoo! Finance]
3/16
04:02 pm
ew
13 U.S. health care stocks to consider in uncertain markets [Globe and Mail, The (Toronto, Canada)]
Low
Report
13 U.S. health care stocks to consider in uncertain markets [Globe and Mail, The (Toronto, Canada)]
3/16
09:59 am
ew
Field Medical Names Mark A. Turco, MD, as Chief Executive Officer [Yahoo! Finance]
Low
Report
Field Medical Names Mark A. Turco, MD, as Chief Executive Officer [Yahoo! Finance]
3/16
09:07 am
ew
Edwards Lifesciences: More Appeal For The Heart [Seeking Alpha]
Low
Report
Edwards Lifesciences: More Appeal For The Heart [Seeking Alpha]